mTOR-IN-31
mTOR-IN-31 is a selective mTOR inhibitor with an IC50 of 0.9 nM. mTOR-IN-31 inhibits the proliferation of prostate cancer cells. mTOR-IN-31 is applicable for cancer-related research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1144075-32-0
- Formule: C20H21N5O2S
- Masse moléculaire:395.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
mTOR 0.9 nM (IC50) |
PI3Kα 423 nM (IC50) |
mTOR-IN-31 (compound 9a) potently inhibits recombinant mTOR with an IC50 of 0.9 nM, and exhibits over 1000-fold selectivity against recombinant PI3K-α[1].
mTOR-IN-31 inhibits the proliferation of human prostate cancer cell line LNCaP (IC50 = 85 nM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1144075-32-0
-
Masse moléculaire 395.48
-
Formule C20H21N5O2S
-
SMILES
O=C(NC)NC1=CC=C(C2=NC3=C(C(N4CC5OC(CC5)C4)=N2)SC=C3)C=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)